125 related articles for article (PubMed ID: 38452755)
21. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults.
Keegan TH; Ries LA; Barr RD; Geiger AM; Dahlke DV; Pollock BH; Bleyer WA;
Cancer; 2016 Apr; 122(7):1009-16. PubMed ID: 26848927
[TBL] [Abstract][Full Text] [Related]
22. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
[TBL] [Abstract][Full Text] [Related]
23. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.
Mikulska M; Del Bono V; Bruzzi P; Raiola AM; Gualandi F; Van Lint MT; Bacigalupo A; Viscoli C
Infection; 2012 Jun; 40(3):271-8. PubMed ID: 22187340
[TBL] [Abstract][Full Text] [Related]
24. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
[TBL] [Abstract][Full Text] [Related]
25. Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine.
AbuTaha SA; Al-Kharraz T; Belkebir S; Abu Taha A; Zyoud SH
Sci Rep; 2022 Oct; 12(1):18003. PubMed ID: 36289278
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Hangai M; Urayama KY; Tanaka J; Kato K; Nishiwaki S; Koh K; Noguchi M; Kato K; Yoshida N; Sato M; Goto H; Yuza Y; Hashii Y; Atsuta Y; Mizuta S; Kato M
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1597-1602. PubMed ID: 31002992
[TBL] [Abstract][Full Text] [Related]
27. Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?
Trama A; Bernasconi A; McCabe MG; Guevara M; Gatta G; Botta L; ; Ries L; Bleyer A
Pediatr Blood Cancer; 2019 Jan; 66(1):e27407. PubMed ID: 30124231
[TBL] [Abstract][Full Text] [Related]
28. [Acute leukemia in adolescents and young adults].
Tomizawa D
Rinsho Ketsueki; 2017; 58(10):2160-2167. PubMed ID: 28978861
[TBL] [Abstract][Full Text] [Related]
29. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Siegel SE; Stock W; Johnson RH; Advani A; Muffly L; Douer D; Reed D; Lewis M; Freyer DR; Shah B; Luger S; Hayes-Lattin B; Jaboin JJ; Coccia PF; DeAngelo DJ; Seibel N; Bleyer A
JAMA Oncol; 2018 May; 4(5):725-734. PubMed ID: 29450465
[TBL] [Abstract][Full Text] [Related]
30. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
[No Abstract] [Full Text] [Related]
31. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
[TBL] [Abstract][Full Text] [Related]
32. Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel).
Cattaneo C; Zappasodi P; Mancini V; Annaloro C; Pavesi F; Skert C; Ferrario A; Todisco E; Saccà V; Verga L; Passi A; Da Vià M; Ferrari S; Mometto G; Petullà M; Nosari A; Rossi G
Ann Hematol; 2016 Dec; 95(12):1955-1963. PubMed ID: 27650830
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and Clinical Characteristics of Bloodstream Infection in Patients Under Extracorporeal Membranous Oxygenation.
Yun JH; Hong SB; Jung SH; Kang PJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
J Intensive Care Med; 2021 Sep; 36(9):1053-1060. PubMed ID: 33375874
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and risk factors for mortality in bloodstream infections: A single-center retrospective study in Japan.
Hattori H; Maeda M; Nagatomo Y; Takuma T; Niki Y; Naito Y; Sasaki T; Ishino K
Am J Infect Control; 2018 Dec; 46(12):e75-e79. PubMed ID: 30172607
[TBL] [Abstract][Full Text] [Related]
36. Distribution and drug resistance profiles of pathogens causing bloodstream infection after chemotherapy in children with acute lymphoblastic leukemia.
Zhan YX; Zhang J; Fan CF; Fan WJ; Xu M
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Feb; 24(2):176-181. PubMed ID: 35209983
[TBL] [Abstract][Full Text] [Related]
37. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
38. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Stock W; La M; Sanford B; Bloomfield CD; Vardiman JW; Gaynon P; Larson RA; Nachman J; ;
Blood; 2008 Sep; 112(5):1646-54. PubMed ID: 18502832
[TBL] [Abstract][Full Text] [Related]
39. Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.
Shimony S; Flamand Y; Valtis YK; Place AE; Silverman LB; Vrooman LM; Brunner AM; Sallan SE; Stone RM; Wadleigh M; Neuberg DS; DeAngelo DJ; Luskin MR
Blood Adv; 2023 Sep; 7(18):5234-5245. PubMed ID: 37432068
[TBL] [Abstract][Full Text] [Related]
40. Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Polish Perspective.
Derwich K; Brzezinski A; Karpenko C; Morar V; Atukoralalage U
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):1-5. PubMed ID: 34232789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
